P. Agapé

发表

(R)-GEMOX chemotherapy for unfit patients with refractory or recurrent primary central nervous system lymphoma: a LOC study

K. Hoang-Xuan, O. Chinot, E. Tabouret, 2018, Annals of Hematology.

Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL.

J. Cayuela, H. Dombret, A. Delannoy, 2016, Blood.

Implication of HTLV-I infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies).

M. Copin, E. Wattel, P. Fenaux, 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease.

J. Cayuela, P. Cony-Makhoul, M. Tulliez, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML

P. Vermersch, J. Pruvo, B. Claise, 2020, European Radiology.

Karyotypic abnormalities in myelofibrosis following polycythemia vera.

F. Bauters, J. Andrieux, P. Agapé, 2003, Cancer genetics and cytogenetics.

High‐dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II study

L. Mannone, P. Fenaux, L. Adès, 2006, British journal of haematology.

Dasatinib (Sprycel®) and Low Intensity Chemotherapy for First-Line Treatment In Elderly Patients with De Novo Philadelphia Positive ALL (EWALL-PH-01): Kinetic of Response, Resistance and Prognostic Significance

J. Cayuela, H. Dombret, A. Delannoy, 2010 .

Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life—experience of the French Network

R. Houot, F. Jardin, K. Hoang-Xuan, 2022, Bone Marrow Transplantation.

Management and outcome of primary CNS lymphoma in the modern era: An LOC network study.

R. Houot, F. Jardin, K. Hoang-Xuan, 2020, Neurology.

Intrasinusoidal Bone Marrow Infiltration Revealing Intravascular Lymphomatosis

P. Dubus, G. Marit, P. Agapé, 2000, Leukemia & lymphoma.

Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience

P. Cony-Makhoul, F. Lacombe, J. Reiffers, 1998, Bone Marrow Transplantation.

Treatment with Hizentra in patients with primary and secondary immunodeficiencies: a real-life, non-interventional trial

C. Gaud, J. Viallard, P. Agapé, 2016, BMC Immunology.

High Response Rate to Darbopoetin Alfa in “Low Risk” MDS : Results of a Phase II Study.

L. Mannone, P. Fenaux, C. Gardin, 2004 .

Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study

K. Hoang-Xuan, O. Chinot, A. Alentorn, 2022, Blood advances.

Analysis of ETV6 and ETV6‐AML1 proteins in acute lymphoblastic leukaemia

H. Cavé, B. Gérard, B. Grandchamp, 1997, British journal of haematology.

Study of apoptosis-related responses of leukemic blast cells to in vitro anthracycline treatment

F. Durrieu, F. Lacombe, J. Reiffers, 2000, Leukemia.

First Results of the Acsé Pembrolizumab Phase II in the Primary CNS Lymphoma (PCNSL) Cohort

R. Houot, F. Jardin, K. Hoang-Xuan, 2020 .

Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric study

P. Cony-Makhoul, J. Reiffers, G. Marit, 1998, Leukemia.

Reply to J. Richter et al.

J. Cayuela, P. Cony-Makhoul, M. Tulliez, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Loss Of Major Molecular Response As a Trigger For Restarting Tyrosine Kinase Inhibitor Therapy In CP-CML Patients Who Have Stopped Imatinib After Durable Undetectable Minimal Residual Disease

J. Cayuela, P. Cony-Makhoul, M. Tulliez, 2013 .

Allogeneic Transplantation for Patients with Advanced Acute Leukemia: a Single Center Retrospective Study of 92 Patients

P. Cony-Makhoul, J. Reiffers, G. Marit, 2001, Leukemia & lymphoma.

Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study

R. Houot, F. Jardin, O. Chinot, 2022, Hematological oncology.

A comparison of toxicity following two different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patients

P. Cony-Makhoul, J. Reiffers, G. Marit, 2001, Bone Marrow Transplantation.

Autologous stem cell transplantation for chronic myeloid leukemia.

P. Cony-Makhoul, J. Reiffers, G. Marit, 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Autologous stem cell transplantation in chronic myeloid leukemia: a single center experience

P. Cony-Makhoul, J. Reiffers, G. Marit, 1999, Bone Marrow Transplantation.

Dasatinib (Sprycel®) and Chemotherapy for First-Line Treatment in Elderly Patients with De Novo Philadelphia Positive ALL: Results of the First 22 Patients Included in the EWALL-Ph-01 Trial (on Behalf of the European Working Group on Adult ALL (EWALL))

J. Cayuela, H. Dombret, A. Delannoy, 2008 .

Dasatinib (Sprycel®) and Low Intensity Chemotherapy for First-Line Treatment in Patients with De Novo Philadelphia Positive ALL Aged 55 and Over: Final Results of the EWALL-Ph-01 Study

J. Cayuela, H. Dombret, A. Delannoy, 2012 .

Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: IFM 2020-04 study.

O. Decaux, P. Moreau, H. Avet-Loiseau, 2023, Haematologica.

Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients

B. Autran, A. Thiébaut, J. Bay, 2013, Vaccine.

The French LOC Network for Primary CNS Lymphoma (PCNSL) Patients: What Can We Learn from a Large National Database?

R. Houot, F. Jardin, K. Hoang-Xuan, 2016 .

FDG-PET/CT findings in systemic mastocytosis: a French multicentre study

M. Soussan, A. Delmer, P. Agapé, 2015, European Journal of Nuclear Medicine and Molecular Imaging.